Home/Filings/4/0001345281-25-000004
4//SEC Filing

RIVA SHEPPARD 4

Accession 0001345281-25-000004

CIK 0001016504other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 5:57 PM ET

Size

7.5 KB

Accession

0001345281-25-000004

Insider Transaction Report

Form 4
Period: 2025-05-21
RIVA KAY
DirectorExecutive Vice President
Transactions
  • Award

    Common Stock

    2025-05-21$0.09/sh+144,445$13,0001,473,467 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2025-05-21144,4450 total
    Exercise: $0.09Exp: 2025-06-02Common Stock (144,445 underlying)
Footnotes (2)
  • [F1]144,445 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
  • [F2]81,945 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016.

Issuer

INTEGRATED BIOPHARMA INC

CIK 0001016504

Entity typeother

Related Parties

1
  • filerCIK 0001064900

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:57 PM ET
Size
7.5 KB